Evidence map›Paper›PMID 37263672›Full record

ArticleBMJ global health2023

A community-based contact isolation strategy to reduce the spread of Ebola virus disease: an analysis of the 2018-2020 outbreak in the Democratic Republic of the Congo.

Mory Keita, Jonathan A Polonsky, Steve Ahuka-Mundeke, Michel Kalongo Ilumbulumbu, Adama Dakissaga, Hamadou Boiro, Julienne Ngoundoung Anoko, Lamine Diassy, John Kombe Ngwama, Houssainatou Bah and 11 more

Open access · goldAbstract read
In one paragraph

Article in BMJ global health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Toward optimal disease surveillance with graph-based active learning.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 8 institutions in 6 countries.

Mory KeitaEmergency Preparedness and Response, World Health Organization Regional Office for Africa, Brazzaville, Congo mokeita@who.int.ORCID 0000-0002-6304-9288
Jonathan A PolonskyGeneva Centre of Humanitarian Studies, University of Geneva, Geneva, Switzerland.ORCID 0000-0002-8634-4255
Steve Ahuka-MundekeDépartement de Virologie, Institut National de Recherche Biomédicale, Kinshasa, Congo (the Democratic Republic of the).
Michel Kalongo IlumbulumbuZone de Santé de Béni, Ministère Provinciale de la Santé, Goma, Congo (the Democratic Republic of the).
Adama DakissagaDirection Régionale de la Santé du Plateau Central, Ministère de la Santé et de l'Hygiène Publique, Ziniaré, Burkina Faso.
Hamadou BoiroEmergency Preparedness and Response, World Health Organization Regional Office for Africa, Brazzaville, Congo.
Julienne Ngoundoung AnokoEmergency Preparedness and Response, World Health Organization Regional Office for Africa, Brazzaville, Congo.
Lamine DiassyEmergency Preparedness and Response, World Health Organization Regional Office for Africa, Brazzaville, Congo.
John Kombe NgwamaDirection Générale de la Lutte contre la Maladie, Ministère de la Santé, Kinshasa, Democratic Republic of Congo.
Houssainatou BahEmergency Preparedness and Response, World Health Organization Regional Office for Africa, Brazzaville, Congo.
Michel Kasereka TosalisanaZone de Santé de Béni, Ministère Provinciale de la Santé, Goma, Congo (the Democratic Republic of the).
Richard Kitenge OmasumbuEquipe Médicale d'Urgence, Ministère de la Santé Publique, Kinshasa, Congo (the Democratic Republic of the).
Ibrahima Sory ChérifCountry Office for Guinea, World Health Organization, Conakry, Guinea.
Samuel T BolandCentre for Universal Health, Chatham House, London, UK.ORCID 0000-0001-6470-5470
Alexandre DelamouAfrican Centre of Excellence for the Prevention and Control of Communicable Diseases, Gamal Abdel Nasser University of Conakry, Conakry, Guinea.
Abdoulaye YamEmergency Preparedness and Response, World Health Organization Regional Office for Africa, Brazzaville, Congo.
Antoine FlahaultInstitute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Stéphanie DagronInstitute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Abdou Salam GueyeEmergency Preparedness and Response, World Health Organization Regional Office for Africa, Brazzaville, Congo.
Olivia KeiserInstitute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Ibrahima Socé FallGlobal Neglected Tropical Diseases programme, World Health Organization, Geneva, Switzerland.
World Health Organization Regional Office for Africa · CGUniversity of Geneva · CHMinistry of Public Health · CDChatham House · GBGamal Abdel Nasser University of Conakry · GNMinistère De La Santé · BFNational Institute of Biomedical Research · CDWorld Health Organization · CH

Funding

World Health Organization 001
6 · The paper itself

Abstract

introductionDespite tremendous progress in the development of diagnostics, vaccines and therapeutics for Ebola virus disease (EVD), challenges remain in the implementation of holistic strategies to rapidly curtail outbreaks. We investigated the effectiveness of a community-based contact isolation strategy to limit the spread of the disease in the Democratic Republic of Congo (DRC).

methodsWe did a quasi-experimental comparison study. Eligible participants were EVD contacts registered from 12 June 2019 to 18 May 2020 in Beni and Mabalako Health Zones. Intervention group participants were isolated to specific community sites for the duration of their follow-up. Comparison group participants underwent contact tracing without isolation. The primary outcome was measured as the reproduction number (R) in the two groups. Secondary outcomes were the delay from symptom onset to isolation and case management, case fatality rate (CFR) and vaccination uptake.

results27 324 EVD contacts were included in the study; 585 in the intervention group and 26 739 in the comparison group. The intervention group generated 32 confirmed cases (5.5%) in the first generation, while the comparison group generated 87 (0.3%). However, the 32 confirmed cases arising from the intervention contacts did not generate any additional transmission (R=0.00), whereas the 87 confirmed cases arising from the comparison group generated 99 secondary cases (R=1.14). The average delay between symptom onset and case isolation was shorter (1.3 vs 4.8 days; p<0.0001), CFR lower (12.5% vs 48.4%; p=0.0001) and postexposure vaccination uptake higher (86.0% vs 56.8%; p<0.0001) in the intervention group compared with the comparison group. A significant difference was also found between intervention and comparison groups in survival rate at the discharge of hospitalised confirmed patients (87.9% vs 47.7%, respectively; p=0.0004).

conclusionThe community-based contact isolation strategy used in DRC shows promise as a potentially effective approach for the rapid cessation of EVD transmission, highlighting the importance of rapidly implemented, community-oriented and trust-building control strategies.

Indexed as

Hemorrhagic Fever, EbolaCase ManagementDemocratic Republic of the CongoDisease OutbreaksHumansVaccinationControl strategiesIntervention studyPublic HealthViral haemorrhagic fevers

Identifiers

PMID37263672
PMCPMC10254818
OpenAlexW4379057244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.